Dengue fever remains a major public health challenge in India, affecting millions every year and causing significant illness and hospitalizations. The arrival of QDENGA, India’s first dengue vaccine, marks a crucial step forward in the fight against this mosquito-borne disease. This vaccine offers hope for reducing the burden of dengue by preventing infections and protecting vulnerable populations. This article explains what QDENGA is, who can receive it, how effective it is,

Dengue fever is a mosquito-borne viral infection that affects millions worldwide every year. While adults often experience a set of well-known symptoms, infants and young children face unique challenges when infected. Their symptoms can differ, complications may arise more quickly, and treatment requires special care. This post explores how dengue fever impacts younger patients differently, highlights prevention strategies tailored for children, and stresses the importance of